CFM
PROK icon

Catalyst Funds Management’s ProKidney PROK Stock Holding History

Catalyst Funds Management’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.6K Buy
+47,800
New +$101K 0.01% 501
2025
Q3 		– Sell
-61,100
Closed -$36.2K – 618
2025
Q2 		$36.2K Buy
+61,100
New +$47.6K 0.01% 393

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Catalyst Funds Management's PROK Position: Q1 2026 in Review

Catalyst Funds Management opened a new position in ProKidney (PROK) in Q1 2026: 47,800 shares worth $85.6K. The stake represents 0.01% of the portfolio and ranks #501 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in PROK as recently as Q2 2025.

Catalyst Funds Management first reported a position in PROK in Q2 2025 and has held it in 2 quarters since. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Catalyst Funds Management held 47,800 shares of ProKidney worth $85.6K as of Q1 2026.
  • ProKidney was a new Catalyst Funds Management position in Q1 2026.
  • ProKidney made up 0.01% of Catalyst Funds Management's portfolio in Q1 2026, its #501 holding.
  • Catalyst Funds Management first reported a position in ProKidney in Q2 2025 and has held it in 2 quarters since.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.